Last updated on November 2017

A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).


Brief description of study

A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

Detailed Study Description

A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor (study medication) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

Clinical Study Identifier: TX15275

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Chelsey

West Michigan Clinical Research Center
Wyoming, MI USA
  Connect »